# Trending Content OS — Daily Run
**Run Date:** 2026-10-25 | **Niche:** Health & Wellness | **Audience:** Health-conscious generalist

---

## 1. Preflight Summary

| Check | Status |
|---|---|
| All 7 configs + CLAUDE.md sections loaded | ✅ |
| `site_niche` / `target_audience` set | ✅ |
| `site_url` | ⚠️ Not set — self-check skipped, competitor-list fallback used (configs/competitor_list.yaml) |
| SerpAPI connected | ✅ |
| Google Trends available | ✅ via injected pre-fetch (`search_velocity_source: google_trends`) |
| Google News Radar injected | ✅ 144 unique headlines / 12 queries |
| `data/deferred_topics.yaml` | Checked — no entries past `recheck_on` today |
| Recurring-theme check (run history) | Flagged: GLP-1 recall, toothpaste recall, AI-diagnosis stories, Women's Health EO all appeared in prior 24–48h — treated as recurring/existing today |
| **Decision** | `next_action: run_signal_listener` (proceeded with manual-synthesis fallback since live tool calls aren't executable in this session; all scoring below is derived directly from the injected SerpAPI/News data, not fabricated) |

---

## 2. Google News Radar Coverage Summary

Clustered the 144 headlines into 8 topic groups:

| Cluster | Disposition | Why |
|---|---|---|
| **FDA recall news** (toothpaste, GLP-1/tirzepatide) | **Rejected — existing** | Both recalls covered in last 7 days (2026-10-23); today's 9+ articles are re-reports of the same facts, no new injury counts or agency action |
| **Women's Health Executive Order / NIH Division** (HHS, Trump/Melania) | **Rejected — existing** | Covered 2026-10-24; Trends shows rising search interest today but no new editorial development to justify an "update" |
| **Medical study cluster** (Stanford preterm-labor, Mass General Brigham AI, PTSD trial, ADHD study, genome/personality studies, pertussis GBD, NIH T-cell, Mayo KRAS) | **Mixed** | Pertussis/NIH/Mayo = existing (dup). Stanford + MGB = **retained** (tier-1 institutional, undercovered). PTSD/ADHD = **rejected at 02b** (unverifiable single secondary source). Genome/personality = monitored (low audience fit) |
| **Clinical trial industry/B2B cluster** (AstraZeneca-Oracle, Syneos-Optum, Milken Institute, wearable accuracy, UK trial speed) | **Rejected — off-category** | Pure pharma/industry business news, excluded category |
| **WHO Ebola vaccine trial (DR Congo)** | **Retained — P1** | Tier-1 institutional source, breaking, infectious disease core category, thin coverage outside wire |
| **Health insurance cost cluster** (KFF, NYT, NPR, Commonwealth Fund) | **Monitored/Rejected** | Credible, timely, but health-economics/policy, not a core evidence-based health/wellness angle for this audience — weak category fit |
| **Wellness lifestyle cluster** (darties, Pilates month, mahjong travel, supplement strips, Barbara O'Neill exposé, Calley Means conflict-of-interest, local wellness fairs/awareness days) | **Mixed** | Local fair/awareness-day items and TikTok/aura/kitchen-gadget trend chatter = rejected (off-category, weak signal, no health evidence angle). Supplement strips + O'Neill misinformation exposé = **retained** (borderline-pass, clear skepticism/evaluation angle) |
| **Celebrity transformation cluster** (Trisha Yearwood, John Goodman, Ethan Klein weight loss) | **Rejected — excluded category** | Celebrity wellness trend, no evidence base |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-10-25T13:00:00Z"
  run_completed_at: "2026-10-25T13:45:00Z"
  total_signals_reviewed: 165
  total_signals_retained: 5
  total_rejected: 160
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 88
    brand_safety: 3
    duplicate: 6
    weak_signal: 59
    unverified_claim: 2
    other: 2
  highest_priority_topic: "WHO Ebola vaccine clinical trial begins in DR Congo"
  strongest_signal_source: "WHO official announcement via Al Jazeera"
  tools_unavailable: ["Reddit live pull", "live SERP top-10 scrape (used competitor-list fallback)"]
  notes: "site_url not configured — self-check skipped; competitor coverage checked instead. Four major stories (toothpaste recall, GLP-1 recall, Women's Health EO, pertussis GBD study, NIH T-cell therapy, Mayo KRAS vaccine) are recurring from the last 48h with no material new development — all rejected as existing. Google Trends shows broad category interest declining (nutrition/diet/fitness all down 4-11pts week-over-week) except gut health (+1) — no single breakout term cleared threshold on its own; all retained candidates were sourced from the Google News Radar institutional/breaking layer."
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Topic | Risk type | Result | Reasoning |
|---|---|---|---|
| WHO Ebola vaccine trial start | clinical_trial | **Pass** (confidence high) | WHO is the primary institutional source announcing its own trial; corroborated by Al Jazeera |
| Stanford digital twins / preterm labor drug | study_or_research | **Pass** (confidence capped Low — single source) | Stanford Medicine is a tier-1 institutional press release; no independent second channel confirms it today |
| Mass General Brigham AI facial recognition study | study_or_research | **Pass** (confidence capped Low — single source) | Tier-1 institutional release; same single-source caveat |
| **PTSD "68% remission" clinical trial (Science Daily)** | clinical_trial / drug_or_treatment_claim | **Reject** — `unverifiable_health_claim` | Science Daily is not a named trusted-secondary outlet for this gate and does not surface a DOI/PubMed/ClinicalTrials.gov identifier in available evidence; single-source, high-stakes treatment claim |
| **ADHD medication self-harm study (Medical Xpress)** | dosage_or_safety_guidance | **Monitor → P5** | Medical Xpress is not a qualifying trusted-secondary for medication-safety claims without a named journal/DOI; reassuring framing lowers harm risk but doesn't clear the bar |
| Barbara O'Neill wellness misinformation exposé | n/a (not a verifiable claim) | **Not applicable** | Reporting on risk of misinformation, not asserting a medical claim itself — gate not triggered |
| Supplement strips trend | n/a (trend piece, not specific efficacy claim) | **Not applicable** | No specific unverifiable health claim being scored; evaluative/skeptical framing required in brief instead |

---

## 5. Final Editorial Priority Board

| Priority | Topic | Primary Entity | Trend | Opp. | Discover | Urgency | Confidence | Status | Sources |
|---|---|---|---|---|---|---|---|---|---|
| **P1** | WHO begins Ebola vaccine clinical trial in DR Congo | WHO / Ebola vaccine | 72 | 75 | 4 | today | high | new | 2 |
| **P3** | Stanford "digital twins" study identifies drug candidates to prevent preterm labor | Stanford Medicine | 55 | 68 | 4 | this_week | low | new | 1 |
| **P3** | Mass General Brigham AI tool assesses age & cancer survival risk from face scans | Mass General Brigham | 58 | 66 | 4 | this_week | low | new | 1 |
| **P3** | Inside the wellness event where "the advice could kill" — vetting dangerous influencer health claims | Barbara O'Neill / wellness influencers | 50 | 62 | 3 | this_week | low | new | 1 |
| **P4** | Supplement strips are replacing gummies — do they actually work? | Supplement strips (category) | 52 | 64 | 3 | this_week | low | new | 1 |

```yaml
priority_board:
  - topic: "WHO begins Ebola vaccine clinical trial in DR Congo"
    priority_level: P1
    publish_timing: immediate
    primary_entity: "WHO / Ebola vaccine trial"
    signal_type: clinical_trial
    allowed_category: "infectious disease"
    trend_strength_score: 72
    opportunity_score: 75
    discover_score: 4
    urgency: today
    confidence: high
    content_status: new
    source_count: 2
    recommended_angle: "What the new Ebola vaccine trial means for outbreak response — explainer on trial design, timeline, and what 'starting a trial' actually means for public risk"
    why_now: "WHO announced trial launch within last 24h; DR Congo has active outbreak history; thin consumer-facing coverage beyond wire reports"
    primary_headline: "WHO Launches Ebola Vaccine Clinical Trial in DR Congo — What to Know"
    next_steps: "Assign immediately; confirm trial phase and enrollment criteria via WHO notice before publish"
    notes: "Institutional primary source (WHO); Al Jazeera corroboration"

  - topic: "Stanford digital-twins study identifies drug candidates to prevent preterm labor"
    priority_level: P3
    publish_timing: scheduled
    primary_entity: "Stanford Medicine"
    signal_type: study_or_research
    allowed_category: "women's health"
    trend_strength_score: 55
    opportunity_score: 68
    discover_score: 4
    urgency: this_week
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "Explain the 'digital twin' immune-system modeling approach in plain language and what it could mean for preterm labor prevention"
    why_now: "Single fresh institutional release, not yet picked up broadly — early-mover opportunity"
    primary_headline: "Scientists Used 'Digital Twins' of the Immune System to Find Drugs That Could Prevent Early Labor"
    next_steps: "Verify underlying journal publication (DOI) before drafting; confidence capped Low pending second source"
    notes: "⚠️ Single-source confidence — do not overstate clinical readiness; this is drug-candidate discovery, not an approved treatment"

  - topic: "Mass General Brigham AI tool assesses age and cancer survival risk from face scans"
    priority_level: P3
    publish_timing: scheduled
    primary_entity: "Mass General Brigham"
    signal_type: study_or_research
    allowed_category: "medical research and clinical trials"
    trend_strength_score: 58
    opportunity_score: 66
    discover_score: 4
    urgency: this_week
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "Distinct from the Microsoft AI-diagnosis story (covered 10/23) — focus specifically on facial-based biological age assessment and what it means for personalized treatment"
    why_now: "New, narrowly-scoped AI health application not yet covered; differentiate explicitly from recent AI-diagnostic-accuracy coverage"
    primary_headline: "This AI Tool Reads Your Face to Predict Cancer Survival Odds — Here's How"
    next_steps: "Confirm it's materially distinct from 10/23 AI-vs-physicians piece in the brief intro to avoid reader fatigue"
    notes: "⚠️ Single-source confidence; clarify this is a research tool, not clinically deployed"

  - topic: "Inside the wellness event where 'the advice could kill'"
    priority_level: P3
    publish_timing: scheduled
    primary_entity: "Barbara O'Neill / wellness influencer circuit"
    signal_type: audience_pain_point
    allowed_category: "public health and epidemiology"
    trend_strength_score: 50
    opportunity_score: 62
    discover_score: 3
    urgency: this_week
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "Skeptical explainer: how to spot dangerous wellness-influencer health advice, using this event as the news hook, reframed for a US audience"
    why_now: "The Guardian's reporting surfaces a live pattern of unlicensed influencers advising against medical care — high audience protection value"
    primary_headline: "The Dangerous Wellness Advice Circulating at Influencer Events — And How to Spot It"
    next_steps: "Localize for US audience; fact-check each specific claim attributed to O'Neill individually before republishing any of them"
    notes: "⚠️ Borderline category pass — justified only by clear debunking/skepticism framing, not promotion of the claims"

  - topic: "Supplement strips are replacing gummies — do they actually work?"
    priority_level: P4
    publish_timing: evergreen
    primary_entity: "Supplement strips (product category)"
    signal_type: product_or_brand_movement
    allowed_category: "nutrition and diet science"
    trend_strength_score: 52
    opportunity_score: 64
    discover_score: 3
    urgency: this_week
    confidence: low
    content_status: new
    source_count: 1
    recommended_angle: "Evaluative: compare absorption/efficacy claims of dissolvable supplement strips vs. gummies/capsules with RDN input"
    why_now: "WSJ-identified emerging consumer trend with no existing evidence-based consumer explainer yet"
    primary_headline: "Supplement Strips Are the New Wellness Craze — But Do They Actually Absorb Better?"
    next_steps: "Pull in RDN source per expert_sources.yaml before drafting; this is evergreen, not time-sensitive"
    notes: "No specific product health claim being verified — frame as category-wide evaluative piece"

summary:
  total_topics: 5
  high_priority_count: 1
  immediate_actions: "Publish WHO Ebola vaccine trial explainer within 24h; queue remaining 4 as P3/P4 this week"
pass_to_next_layer: false
```

---

## 6. Editorial Briefs

### P1 — WHO Ebola Vaccine Clinical Trial (DR Congo)
- **Headlines:** "WHO Launches Ebola Vaccine Clinical Trial in DR Congo — What to Know" / "A New Ebola Vaccine Trial Just Started. Here's Why It Matters" / "Inside the New Ebola Vaccine Trial Underway in DR Congo"
- **Angle:** Explain what "starting a trial" means in practice (phase, population, timeline) and public-health stakes given DR Congo's outbreak history.
- **Key data points:** Trial announced by WHO 10/24; DR Congo context; vaccine trial phase (verify before publish).
- **Expert source:** WHO spokesperson statement (official); cite a named infectious-disease epidemiologist per expert_sources.yaml if available in WHO release.
- **SEO:** primary keyword "Ebola vaccine trial DR Congo"; supporting: "Ebola outbreak 2026," "new Ebola vaccine."
- **Sources:**
  - WHO (official notice) — [https://www.who.int](https://www.who.int) — tier 1 — primary announcement [URL unverified, confirm direct WHO notice link before publish]
  - Al Jazeera — [https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo](https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo) — tier 2 — corroboration
- **Integrity flag:** ⚠️ Do not imply the vaccine is approved or widely available — this is a trial, not a rollout.
- **Est. word count:** 900–1100

### P3 — Stanford Preterm Labor "Digital Twins" Study
- **Angle:** Plain-language explainer of digital-twin immune modeling + candidate drugs identified.
- **Key data:** Stanford Medicine-led study (verify journal/DOI pre-publish).
- **Integrity flag:** ⚠️ Early-stage drug-candidate discovery, not a clinical treatment — avoid "cure" framing.
- **Expert type needed:** OB/GYN or maternal-fetal medicine specialist.
- **SEO:** "digital twin pregnancy study," format: explainer, SERP difficulty: Easy.
- **Source:** Stanford Medicine — [https://med.stanford.edu/news/all-news/2026/10/preterm-labor-drug.html](https://med.stanford.edu/news/all-news/2026/10/preterm-labor-drug.html)
- **Est. word count:** 600–750

### P3 — Mass General Brigham AI Facial Health Recognition
- **Angle:** What this specific tool does (biological age + cancer survival risk from facial scans), explicitly distinguished from the 10/23 Microsoft AI-diagnosis story.
- **Integrity flag:** ⚠️ Research-stage tool, not clinically deployed — avoid implying patients can access this now.
- **Expert type needed:** Oncologist or geriatrician.
- **SEO:** "AI facial age cancer risk tool," format: explainer, SERP difficulty: Easy.
- **Source:** Mass General Brigham — [https://news.massgeneralbrigham.org/en/ai-facial-recognition-tools-assess-age-cancer-survival-risk](https://news.massgeneralbrigham.org/en/ai-facial-recognition-tools-assess-age-cancer-survival-risk)
- **Est. word count:** 600–750

### P3 — Dangerous Wellness Influencer Advice
- **Angle:** Skeptical, protective framing — how to spot influencers advising against medical care; localize to US-relevant examples.
- **Integrity flag:** ⚠️ Fact-check each specific claim attributed to O'Neill individually; do not repeat unverified claims without caveat.
- **Expert type needed:** Public health communication expert or physician commenting on health misinformation.
- **SEO:** "wellness influencer dangerous advice," format: explainer/listicle, SERP difficulty: Medium.
- **Source:** The Guardian — [https://www.theguardian.com/society/2026/oct/18/influencers-wellness-event-cheshire-barbara-oneill-australian](https://www.theguardian.com/society/2026/oct/18/influencers-wellness-event-cheshire-barbara-oneill-australian)
- **Est. word count:** 700–900

### P4 — Supplement Strips Trend
- **Angle:** Evaluative — do dissolvable supplement strips absorb better than gummies/capsules?
- **Integrity flag:** ⚠️ No peer-reviewed absorption data cited yet — flag as emerging category, not validated.
- **Expert type needed:** Registered Dietitian Nutritionist (RDN).
- **SEO:** "supplement strips vs gummies," format: evaluative explainer, SERP difficulty: Easy.
- **Source:** WSJ — [https://www.wsj.com/health/wellness/supplement-strips-stripit-sleep-or-die-0f69c8d7](https://www.wsj.com/health/wellness/supplement-strips-stripit-sleep-or-die-0f69c8d7)
- **Est. word count:** 500–650

---

## 7. Rejected Topics Log

| Topic | Reason |
|---|---|
| HHS/NIH Women's Health Executive Order | Existing — covered 10/24, no new development |
| Pertussis resurgence (Global Burden of Disease) | Existing — covered 10/23 |
| NIH precision T-cell therapy | Existing — covered 10/24 |
| Mayo Clinic KRAS pancreatic vaccine | Existing — covered 10/24 |
| Toothpaste recall (Brush Buddies) | Existing — covered 10/23, no new injury/agency data today |
| GLP-1/tirzepatide recall | Existing — covered 10/23 |
| PTSD "68% remission" clinical trial (Science Daily) | **02b reject** — unverifiable health claim, no traceable primary source |
| ADHD medication self-harm study (Medical Xpress) | **02b monitor → P5** — secondary source doesn't meet trusted-outlet bar for medication-safety claims |
| Trisha Yearwood / John Goodman / Ethan Klein weight loss | Excluded — celebrity wellness trend, no evidence base |
| Health insurance cost cluster (KFF/NYT/NPR/Commonwealth Fund) | Off-category — health economics/policy, weak audience fit for evidence-based health content |
| Penn Medicine personality genetics study | Monitor — low audience relevance, edge category fit |
| "Average human genome" study (News-Medical) | Monitor — single secondary source, unclear primary citation |
| Nature "personal health agent" AI piece | Monitor — thematic overlap with 10/23 AI-diagnosis coverage |
| Clinical-trial industry/B2B cluster (AstraZeneca-Oracle, Syneos-Optum, Milken Institute, wearables, UK trial speed) | Excluded — pure pharma/industry business news |
| Local wellness fairs/awareness days (Purdue, UTSA, Georgia Tech, Fort McCoy, Delaware County, EPA Children's Health Month, One Health Day) | Off-category — local/promotional, not national-audience relevant |
| Consumer lifestyle trend chatter (TikTok trends, beauty hacks, aura points, non-toxic air fryers, mahjong travel, Pilates month, wellness darties) | Weak signal / off-category — no health-evidence angle |
| Calley Means wellness-company stake story (NYT) | Monitor — political/conflict-of-interest angle, borderline per brand safety rules on political drift |

---

## 8. Integrity Flags (Consolidated)

- ⚠️ **WHO Ebola trial:** Do not imply vaccine approval or availability — trial stage only.
- ⚠️ **Stanford preterm labor study:** Early drug-candidate discovery, not a treatment; confidence capped Low pending second source/DOI confirmation.
- ⚠️ **MGB AI facial tool:** Research-stage, not clinically deployed; distinguish explicitly from 10/23 AI-diagnosis coverage to avoid reader fatigue/confusion.
- ⚠️ **Wellness influencer piece:** Fact-check each specific claim individually before republishing; do not amplify unverified claims even in a debunking frame.
- ⚠️ **Supplement strips:** No peer-reviewed absorption data yet; frame as emerging, unvalidated category.
- ⚠️ **ADHD/PTSD studies (rejected/monitored):** Do not resurrect for scoring without a named journal, DOI, or trial registry ID.

---

## 9. Run Notes

- Google Trends shows broad softening across core category keywords this week (nutrition -5, fitness -5, food safety -11, diet -4) — no single term cleared breakout threshold; today's retained candidates came from the News Radar institutional layer rather than search-velocity spikes.
- Four stories recurring from the prior 48h (toothpaste recall, GLP-1 recall, Women's Health EO, pertussis/NIH/Mayo studies) were correctly suppressed as `existing` — recommend flagging these as a 3-day recurrence pattern in tomorrow's run_history check if they resurface again without new developments.
- `site_url` remains unconfigured — all duplicate/SERP-gap judgments used competitor-list fallback and the provided Recent Coverage list; recommend connecting a content database for stronger self-check fidelity.
- Confidence was capped Low on 4 of 5 retained candidates due to single-source sourcing (institutional press releases without a second independent channel) — acceptable per the confidence rubric, but these briefs should get a second-source pass before publish where possible.
- No candidates required deferral this run (max_candidates_returned of 25 not approached).